Peter Brown

Stock price provided by Lang & Schwarz

Showing transactions by Peter Brown in Adaptimmune Therapeutics plc.

Quarter	Type	Shares before	Shares after	Change	Price range
2025-Q1	Sell	2.5M	1.8M	-713K	€0.19–€0.66
2024-Q4	Buy	1.7M	2.5M	+870K	€0.55–€0.87
2024-Q3	Sell	1.8M	1.7M	-130K	€0.85–€1.29
2024-Q2	Buy	1.4M	1.8M	+395K	€0.81–€1.38
2024-Q1	Buy	1.4M	1.4M	+22K	€0.61–€1.61
2023-Q4	Buy	1M	1.4M	+342K	€0.37–€0.71
2023-Q3	Sell	1.5M	1M	-479K	€0.67–€0.89
2023-Q2	Buy	183K	1.5M	+1.3M	€0.79–€1.35
2023-Q1	Sell	561K	183K	-378K	€0.95–€2.08
2022-Q4	Sell	566K	561K	-5.3K	€1.09–€2.46
2022-Q3	Buy	510K	566K	+56K	€1.05–€2.36
2022-Q2	Sell	960K	510K	-450K	€1.26–€2.06
2022-Q1	Buy	428K	960K	+532K	€1.58–€3.52
2021-Q4	Buy	303K	428K	+124K	€3.04–€4.88
2021-Q2	Buy	101K	303K	+202K	€3.16–€4.74
2021-Q1	Sell	892K	101K	-791K	€3.90–€5.85
2020-Q4	Sell	1.3M	892K	-430K	€3.32–€7.25
2020-Q3	Sell	1.7M	1.3M	-384K	€6.40–€9.35
2020-Q2	Sell	1.7M	1.7M	-45K	€2.32–€10.40
2020-Q1	Buy	1.5M	1.7M	+285K	€1.04–€4.48
2019-Q4	Buy	879K	1.5M	+586K	€0.67–€1.32
2019-Q3	Buy	497K	879K	+382K	€1.25–€3.52
2019-Q2	Sell	795K	497K	-297K	€2.84–€4.52
2019-Q1	Buy	626K	795K	+168K	€3.22–€5.15
2018-Q4	Sell	1M	626K	-408K	€3.24–€12.00
2018-Q3	Sell	1.3M	1M	-272K	€7.20–€11.40
2018-Q1	Buy	994K	1.3M	+312K	€5.82–€9.80
2017-Q4	Sell	1.2M	994K	-161K	€5.51–€7.42
2017-Q3	Buy	1.1M	1.2M	+86K	€3.84–€7.38
2017-Q2	Buy	781K	1.1M	+289K	€3.87–€5.85
2017-Q1	Buy	445K	781K	+336K	€3.66–€5.10
2016-Q4	Buy	329K	445K	+116K
2016-Q3	Buy	189K	329K	+140K
2016-Q2	Buy	113K	189K	+76K
2016-Q1	Buy	29K	113K	+84K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors